1ST Source Bank Purchases New Shares in GRAIL, Inc. (NASDAQ:GRAL)

1ST Source Bank acquired a new position in shares of GRAIL, Inc. (NASDAQ:GRAL - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 8,487 shares of the company's stock, valued at approximately $217,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Caldwell Sutter Capital Inc. bought a new position in GRAIL in the first quarter worth about $28,000. KBC Group NV lifted its stake in shares of GRAIL by 187.7% in the 1st quarter. KBC Group NV now owns 1,430 shares of the company's stock valued at $37,000 after purchasing an additional 933 shares during the period. S.A. Mason LLC lifted its stake in shares of GRAIL by 50.1% in the 1st quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock valued at $38,000 after purchasing an additional 500 shares during the period. State of Tennessee Department of Treasury purchased a new stake in GRAIL in the 4th quarter worth $28,000. Finally, Sterling Capital Management LLC purchased a new stake in GRAIL in the 4th quarter worth $29,000.

Insider Transactions at GRAIL

In related news, major shareholder Chun R. Ding sold 339,800 shares of the company's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $49.53, for a total transaction of $16,830,294.00. Following the completion of the transaction, the insider directly owned 3,305,055 shares in the company, valued at $163,699,374.15. This represents a 9.32% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Robert P. Ragusa sold 94,035 shares of the company's stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total value of $3,190,607.55. Following the transaction, the chief executive officer owned 734,627 shares of the company's stock, valued at approximately $24,925,894.11. The trade was a 11.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 540,890 shares of company stock valued at $23,868,412.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group boosted their price target on shares of GRAIL from $32.00 to $43.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th.

GRAIL Price Performance

GRAIL stock traded up $3.12 during midday trading on Tuesday, hitting $37.47. 911,820 shares of the company were exchanged, compared to its average volume of 1,157,889. The company's fifty day moving average price is $41.81 and its 200-day moving average price is $34.43. The company has a market cap of $1.35 billion and a PE ratio of -0.61. GRAIL, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99.

GRAIL (NASDAQ:GRAL - Get Free Report) last announced its earnings results on Tuesday, May 13th. The company reported ($3.10) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($4.03) by $0.93. GRAIL had a negative return on equity of 17.99% and a negative net margin of 1,464.53%. The company had revenue of $31.84 million for the quarter, compared to analyst estimates of $35.80 million. On average, analysts expect that GRAIL, Inc. will post -15.15 EPS for the current fiscal year.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.